Not signed in (Sign In)

Vanilla 1.1.2 is a product of Lussumo. More Information: Documentation, Community Support.

    •  
      CommentAuthorSusan L*
    • CommentTimeJun 13th 2010
     
    I just found out that my nephews father-in-law is in acute renal failure. I sat and talked with his wife and she told me that they went for colonoscopys together last year. They both drank the phosphorus preparation. He reacted to his and it caused the valves leading to his kidneys to be damaged leading to kidney failure. He has constant pneumonia, and is going onto dialysis soon. His creatinine levels are way to high, and he first needs to be on dialysis before they will put him on a transplant list. This was a perfectly healthy 60 ish yr old guy with no health problems! I can't believe it. Has anyone else ever heard of anything like this?

    Maybe Marsh can shed some light on this horrible side effect.

    Please keep David in your prayers and his lovely British wife Alison.
    • CommentAuthorJan K
    • CommentTimeJun 13th 2010
     
    When I found out last year that I had kidney disease, this is one of the things that the nephrologist cautioned me about. He said that at least one of the things they give people for this test can cause kidney disease in somebody who has never had it—but it's especially bad for somebody who already has kidney disease. This is just another one of the many things that I wish doctors would give you more information on. (Some of the dyes they use for CT scans are not good if you have any kidney impairment, either.)
    •  
      CommentAuthordeb112958
    • CommentTimeJun 13th 2010
     
    When I had my colonoscopy last year, the prep did not include any sodium phosphate products. I did the dulcolax, citrate of magnesium and miralax with gatorade prep and the doctor said I was clean as a whistle :)

    I FOUND THIS ARTICLE ON WEBMD.COM:

    Dec. 11, 2008 -- The FDA today ordered a "black box" warning, the FDA's sternest warning, for the prescription oral sodium phosphate products Visicol and OsmoPrep, which are used to cleanse the bowel before a colonoscopy and other medical procedures.

    The warning pertains to the risk of acute phosphate nephropathy, which is a type of acute kidney injury.

    The FDA also recommends that consumers not use over-the-counter oral sodium phosphate products, such as Fleet Phospho-soda, for bowel cleansing.

    According to the FDA, over-the-counter oral sodium phosphate products, when used for bowel cleansing, pose the same kidney risk as the prescription oral sodium phosphate products. But that risk doesn't apply to those over-the-counter products used as laxatives.

    Kidney Injury Reports
    The FDA has received 20 reports of kidney injury associated with OsmoPrep since OsmoPrep's approval in 2006. Three of those cases were confirmed by biopsy. Some cases happened within hours of use; others were reported days or weeks later.

    The FDA has also received reports of 19 cases of acute renal (kidney) failure, seven of which were confirmed by biopsy.

    Korvik notes that one reason for the risk might be that some people may be dehydrated and not drinking enough fluid when they use oral sodium phosphate products for bowel cleansing, despite the instructions on the products.

    "We don't believe that all of the patients are at risk," Korvik said at a news conference.

    Charles Ganley, MD, who directs the FDA's Office of Nonprescription Products, agrees, noting that "the majority" of patients who use those products "don't run into problems."

    The FDA has asked Salix Pharmaceuticals, which makes Visicol and OsmoPrep, to do a study to learn more about the kidney risk and how to manage it.

    Spokespeople for Salix Pharmaceuticals and for C.B. Fleet Company, which makes Fleet Phospho-soda, were not immediately available for comment.

    No Reason to Postpone Colonoscopy
    Patients 18 and older can still use Visicol and OsmoPrep for bowel cleansing before colonoscopy or other procedures.

    But the FDA recommends that people use caution with those products if they are in the following risk groups:

    People older than 55
    People with dehydration, kidney disease, acute colitis, or delayed bowel emptying
    People taking certain medicines that affect kidney function, such as diuretics, ACE inhibitors, angiotensin receptor blockers, and possibly nonsteroidal anti-inflammatory drugs (NSAIDs).
    The FDA's warning doesn't apply to Golytely, Colyte, Nulytely, Trilyte, and Halflytely, which are polyethylene glycol preparations that can be used for bowel cleansing.